<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>100(11)</volume><submitter>Fritz N</submitter><funding>Universitätsklinikum Heidelberg</funding><funding>Medizinischen Fakultät Heidelberg, Universität Heidelberg</funding><pubmed_abstract>Irritable bowel syndrome (IBS) is a gut-brain disorder of multifactorial origin. Evidence of disturbed serotonergic function in IBS accumulated for the 5-HT&lt;sub>3&lt;/sub> receptor family. 5-HT&lt;sub>3&lt;/sub>Rs are encoded by HTR3 genes and control GI function, and peristalsis and secretion, in particular. Moreover, 5-HT&lt;sub>3&lt;/sub>R antagonists are beneficial in the treatment of diarrhea predominant IBS (IBS-D). We previously reported on functionally relevant SNPs in HTR3A c.-42C > T (rs1062613), HTR3C p.N163K (rs6766410), and HTR3E c.*76G > A (rs56109847 = rs62625044) being associated with IBS-D, and the HTR3B variant p.Y129S (rs1176744) was also described within the context of IBS. We performed a multi-center study to validate previous results and provide further evidence for the relevance of</pubmed_abstract><journal>Journal of molecular medicine (Berlin, Germany)</journal><pagination>1617-1627</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9592668</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The serotonin receptor 3E variant is a risk factor for female IBS-D.</pubmed_title><pmcid>PMC9592668</pmcid><pubmed_authors>Dinan TG</pubmed_authors><pubmed_authors>Gazouli M</pubmed_authors><pubmed_authors>Sayuk G</pubmed_authors><pubmed_authors>Dong Y</pubmed_authors><pubmed_authors>Raithel M</pubmed_authors><pubmed_authors>Schmidt B</pubmed_authors><pubmed_authors>Goebel-Stengel M</pubmed_authors><pubmed_authors>Nothen MM</pubmed_authors><pubmed_authors>Tesarz J</pubmed_authors><pubmed_authors>Lieb W</pubmed_authors><pubmed_authors>Schmitteckert S</pubmed_authors><pubmed_authors>Kabisch M</pubmed_authors><pubmed_authors>Madrid AM</pubmed_authors><pubmed_authors>Schaefert R</pubmed_authors><pubmed_authors>Kennedy PJ</pubmed_authors><pubmed_authors>Berens S</pubmed_authors><pubmed_authors>Gotze D</pubmed_authors><pubmed_authors>Spiller R</pubmed_authors><pubmed_authors>Herzog W</pubmed_authors><pubmed_authors>Keller J</pubmed_authors><pubmed_authors>Vicario M</pubmed_authors><pubmed_authors>Zheng T</pubmed_authors><pubmed_authors>Beltran C</pubmed_authors><pubmed_authors>Heilmann-Heimbach S</pubmed_authors><pubmed_authors>Frieling T</pubmed_authors><pubmed_authors>Hoffmann P</pubmed_authors><pubmed_authors>Martinez C</pubmed_authors><pubmed_authors>Gauss A</pubmed_authors><pubmed_authors>Niesler B</pubmed_authors><pubmed_authors>Roth R</pubmed_authors><pubmed_authors>Bustamante M</pubmed_authors><pubmed_authors>Wouters MM</pubmed_authors><pubmed_authors>D'Amato M</pubmed_authors><pubmed_authors>Monnikes H</pubmed_authors><pubmed_authors>Quigley EMM</pubmed_authors><pubmed_authors>Franke A</pubmed_authors><pubmed_authors>Fritz N</pubmed_authors><pubmed_authors>Torres V</pubmed_authors><pubmed_authors>Santos J</pubmed_authors><pubmed_authors>Karamanolis G</pubmed_authors><pubmed_authors>Andresen V</pubmed_authors><pubmed_authors>Engel F</pubmed_authors><pubmed_authors>Simren M</pubmed_authors><pubmed_authors>Lorenzo-Bermejo J</pubmed_authors><pubmed_authors>Wahl V</pubmed_authors><pubmed_authors>Houghton LA</pubmed_authors><pubmed_authors>Estivil X</pubmed_authors><pubmed_authors>Boeckxstaens G</pubmed_authors><pubmed_authors>Rabionet R</pubmed_authors><pubmed_authors>Clarke G</pubmed_authors><pubmed_authors>Rappold GA</pubmed_authors><pubmed_authors>Stein-Thoringer C</pubmed_authors><pubmed_authors>Cryan JF</pubmed_authors><pubmed_authors>Mayer EA</pubmed_authors><pubmed_authors>Pehl C</pubmed_authors></additional><is_claimable>false</is_claimable><name>The serotonin receptor 3E variant is a risk factor for female IBS-D.</name><description>Irritable bowel syndrome (IBS) is a gut-brain disorder of multifactorial origin. Evidence of disturbed serotonergic function in IBS accumulated for the 5-HT&lt;sub>3&lt;/sub> receptor family. 5-HT&lt;sub>3&lt;/sub>Rs are encoded by HTR3 genes and control GI function, and peristalsis and secretion, in particular. Moreover, 5-HT&lt;sub>3&lt;/sub>R antagonists are beneficial in the treatment of diarrhea predominant IBS (IBS-D). We previously reported on functionally relevant SNPs in HTR3A c.-42C > T (rs1062613), HTR3C p.N163K (rs6766410), and HTR3E c.*76G > A (rs56109847 = rs62625044) being associated with IBS-D, and the HTR3B variant p.Y129S (rs1176744) was also described within the context of IBS. We performed a multi-center study to validate previous results and provide further evidence for the relevance of</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2026-05-27T11:47:45.171Z</modification><creation>2024-11-21T00:15:44.612Z</creation></dates><accession>S-EPMC9592668</accession><cross_references><pubmed>36121467</pubmed><doi>10.1007/s00109-022-02244-w</doi></cross_references></HashMap>